1.770USD-1.12%Mkt Cap: 58.52M USDP/E: 1.49Last update: 2026-05-26
Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on the development of medicine to treat pain and fatigue-related disorders. Its lead product candidates include IMC-1, a combination of famci…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
105.81BDKKP/E 20.4
66.47BUSDP/E 15.5
46.56BEURP/E 30.5
43.89BEURP/E 36.5
39.41BUSDP/E 74.0
32.84BUSD—
32.05BSEKP/E 47.4
Indicators:|
Key Statistics
Company
Market Cap58.52M USD
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-34.26M USD
Revenue/Share—
Last Price1.770 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees8
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)1.49
P/E (Forward)-0.28
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.72
EPS (TTM)1.17
EPS (Forward)-6.37
52W Range
1.2806% of range9.500
52W High9.500 USD
52W Low1.280 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-45.74%
ROA-37.99%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.62M USD
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.00
Current Ratio—
Quick Ratio—
Book Value/Sh2.518 USD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:25
Split DateOct 9, 2024
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)14.00 USD
Target Range12.00 USD – 15.00 USD
# Analysts3
Ownership
Shares Out.33.63M
Float4.80M
Insiders74.49%
Institutions10.97%
Short Interest
Short Ratio1.0d
Short % Float1.08%
Short % Out.0.38%
Shares Short125.51K
Short (prev mo.)70.61K
Technical
SMA 501.956 (-9.5%)
SMA 2004.078 (-56.6%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)126.01K
Avg Vol (10d)80.32K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—